International Journal of Theranostics

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Loss of Numb in breast carcinogenesis: a paradigm for a mechanism-based selective anti-cancer stem cell therapy

The cell fate determinant Numb could be a tumour suppressor within the exocrine gland whose loss in human breast cancers ends up in p53 inactivation Associate in Nursingd an aggressive malady course. Numb-p53 downregulation results in aberrant exocrine gland ontogeny and emergence of cancer stem cells (CSCs). Numb-deficient CSCs show unlimited self-renewal and proliferative potential, that could be a operate of their ability to execute unbridled self-renewing isobilateral divisions. These phenotypes that may be reverted by Numb-p53 restoration during a Numb-knockout mouse model, disceptation that targeting Numb-p53 disfunction in Numb-deficient human carcinoma might represent a completely unique anti-CSC medical aid. mistreatment patient-derived xenografts, we’ve got recently incontestable that enlargement of the CSC pool, thanks to altered self-renewing divisions, is additionally a characteristic feature of present Numb-deficient human breast cancers. In these cancers, mistreatment the matter Nutlin-3 to revive p53, we have a tendency to corrected the defective self-renewal properties of Numb-deficient CSCs and inhibited CSC enlargement, therefore kerb tumorigenicity and metastasis. 

Special Features

Full Text

View

Track Your Manuscript

Media Partners

GET THE APP